# Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

> **NCT03903822** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 292 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** PF-06700841
- **DRUG:** Vehicle (Placebo)

## Key facts

- **NCT ID:** NCT03903822
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-13
- **Primary completion:** 2020-05-07
- **Final completion:** 2020-05-07
- **Target enrollment:** 292 (ACTUAL)
- **Last updated:** 2021-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03903822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03903822, "Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03903822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*